Review
doi: 10.1002/(SICI)1098-1128(199603)16:2<125::AID-MED1>3.0.CO;2-2.
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development
Affiliations
- PMID: 8656777
- DOI: 10.1002/(SICI)1098-1128(199603)16:2<125::AID-MED1>3.0.CO;2-2
Item in Clipboard
Review
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development
Med Res Rev.
1996 Mar.
No abstract available
Similar articles
-
Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.Leukemia. 1995 Oct;9 Suppl 1:S75-85. Leukemia. 1995. PMID: 7475321
-
[Highly specific inhibitors of human immunodeficiency virus type I that are particularly targeted at the reverse transcriptase].Pathol Biol (Paris). 1993 Mar;41(3):230-6. Pathol Biol (Paris). 1993. PMID: 7687340 Review. French. No abstract available.
-
In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.J Virol. 2004 Dec;78(24):13553-61. doi: 10.1128/JVI.78.24.13553-13561.2004. J Virol. 2004. PMID: 15564466 Free PMC article.
-
[Mechanisms of HIV-1 drug resistance to nucleoside and non-nucleoside reverse transcriptase inhibitors].Mol Biol (Mosk). 2011 Jan-Feb;45(1):108-26. Mol Biol (Mosk). 2011. PMID: 21485502 Review. Russian.
-
Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors.J Med Chem. 1996 Aug 2;39(16):3217-27. doi: 10.1021/jm960082v. J Med Chem. 1996. PMID: 8759644
Cited by
-
Mode of inhibition of HIV-1 reverse transcriptase by polyacetylenetriol, a novel inhibitor of RNA- and DNA-directed DNA polymerases.Biochem J. 2002 Mar 15;362(Pt 3):685-92. doi: 10.1042/0264-6021:3620685. Biochem J. 2002. PMID: 11879196 Free PMC article.
-
Pharmacokinetics of BILR 355 after multiple oral doses coadministered with a low dose of ritonavir.Antimicrob Agents Chemother. 2009 Jan;53(1):95-103. doi: 10.1128/AAC.00752-08. Epub 2008 Oct 27. Antimicrob Agents Chemother. 2009. PMID: 18955519 Free PMC article. Clinical Trial.
-
Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260).Antimicrob Agents Chemother. 2000 Mar;44(3):794-7. doi: 10.1128/AAC.44.3.794-797.2000. Antimicrob Agents Chemother. 2000. PMID: 10681363 Free PMC article. Clinical Trial.
-
In search of a selective antiviral chemotherapy.Clin Microbiol Rev. 1997 Oct;10(4):674-93. doi: 10.1128/CMR.10.4.674. Clin Microbiol Rev. 1997. PMID: 9336668 Free PMC article. Review.
-
Development and preclinical studies of broad-spectrum anti-HIV agent (3'R,4'R)-3-cyanomethyl-4-methyl-3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone (3-cyanomethyl-4-methyl-DCK).J Med Chem. 2008 Dec 25;51(24):7689-96. doi: 10.1021/jm8003009. J Med Chem. 2008. PMID: 19053755 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
